| 1 | [SID103634685] | Active | Ki | 0.53 | Inhibition of rat ecto-5'-nucleotidase expressed in Sf9 cells by capillary electrophoresis method [AID461575, Type: Literature] | 5'-nucleotidase [gi:112826] |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103634685 | | CID | 24868313 | | Outcome | Active | | Ki | 0.53 [uM] | | BioAssay | Inhibition of rat ecto-5'-nucleotidase expressed in Sf9 cells by capillary electrophoresis method | | AID | 461575 | | BioAssay type | Literature | | Target | 5'-nucleotidase [gi:112826] | | PubMed | 20146483 | | Data Table |  |
|
| 2 | [SID103634685] | Active | Ki | 1.5 | Inhibition of rat NTPdase3 by capillary electrophoresis method [AID461583, Type: Literature] | Nucleoside triphosphate diphosphohydrolase 3 [gi:81865998] |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103634685 | | CID | 24868313 | | Outcome | Active | | Ki | 1.5 [uM] | | BioAssay | Inhibition of rat NTPdase3 by capillary electrophoresis method | | AID | 461583 | | BioAssay type | Literature | | Target | Nucleoside triphosphate diphosphohydrolase 3 [gi:81865998] | | PubMed | 20146483 | | Data Table |  |
|
| 3 | [SID103634685] | Active | IC50 | 6.67 | Antagonist activity at human P2Y2 receptor expressed in astrocytoma cells assessed as inhibition of intracellular calcium mobilization [AID461585, Type: Literature] | P2Y purinoceptor 2 [gi:311033490] |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103634685 | | CID | 24868313 | | Outcome | Active | | IC50 | 6.67 [uM] | | BioAssay | Antagonist activity at human P2Y2 receptor expressed in astrocytoma cells assessed as inhibition of intracellular calcium mobilization | | AID | 461585 | | BioAssay type | Literature | | Target | P2Y purinoceptor 2 [gi:311033490] | | PubMed | 20146483 | | Data Table |  |
|
| 4 | [SID103634685] | Active | IC50 | 10.1 | Antagonist activity at human P2Y4 receptor expressed in astrocytoma cells assessed as inhibition of intracellular calcium mobilization [AID461776, Type: Literature] | P2Y purinoceptor 4 [gi:1709524] |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103634685 | | CID | 24868313 | | Outcome | Active | | IC50 | 10.1 [uM] | | BioAssay | Antagonist activity at human P2Y4 receptor expressed in astrocytoma cells assessed as inhibition of intracellular calcium mobilization | | AID | 461776 | | BioAssay type | Literature | | Target | P2Y purinoceptor 4 [gi:1709524] | | PubMed | 20146483 | | Data Table |  |
|
| 5 | [SID50112917] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 6 | [SID50112917] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 7 | [SID50112917] | Active | Potency | 22.3872 | qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) [AID2549, Type: confirmatory] | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) | | AID | 2549 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] | | PubMed | | | Data Table |  |
|
| 8 | [SID103634685] | Active | IC50 | 30 | Antagonist activity at rat P2Y6 receptor expressed in astrocytoma cells assessed as inhibition of intracellular calcium mobilization [AID461777, Type: Literature] | P2Y purinoceptor 6 [gi:2495019] |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103634685 | | CID | 24868313 | | Outcome | Active | | IC50 | 30 [uM] | | BioAssay | Antagonist activity at rat P2Y6 receptor expressed in astrocytoma cells assessed as inhibition of intracellular calcium mobilization | | AID | 461777 | | BioAssay type | Literature | | Target | P2Y purinoceptor 6 [gi:2495019] | | PubMed | 20146483 | | Data Table |  |
|
| 9 | [SID50112917] | Active | Potency | 35.4813 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 10 | [SID50112917] | Active | Potency | 35.4813 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 11 | [SID50112917] | Active | Potency | 35.4813 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 12 | [SID50112917] | Active | Potency | 35.4813 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 13 | [SID103634685] | Active | | | Inhibition of rat ecto-5'-nucleotidase expressed in Sf9 cells by competitive Lineweaver-Burke plot [AID461578, Type: Literature] | 5'-nucleotidase [gi:112826] |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103634685 | | CID | 24868313 | | Outcome | Active | | BioAssay | Inhibition of rat ecto-5'-nucleotidase expressed in Sf9 cells by competitive Lineweaver-Burke plot | | AID | 461578 | | BioAssay type | Literature | | Target | 5'-nucleotidase [gi:112826] | | PubMed | 20146483 | | Data Table |  |
|
| 14 | [SID103634685] | Active | | | Inhibition of rat ecto-5'-nucleotidase expressed in Sf9 cells by competitive Michaelis-Menten plot [AID461577, Type: Literature] | 5'-nucleotidase [gi:112826] |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103634685 | | CID | 24868313 | | Outcome | Active | | BioAssay | Inhibition of rat ecto-5'-nucleotidase expressed in Sf9 cells by competitive Michaelis-Menten plot | | AID | 461577 | | BioAssay type | Literature | | Target | 5'-nucleotidase [gi:112826] | | PubMed | 20146483 | | Data Table |  |
|
| 15 | [SID103634685] | Unspecified | IC50 | 10 | Antagonist activity against rat P2X4 receptor expressed in Xenopus laevis oocyte assessed as inhibition of alpha, beta-meATP-induced inward current by two-electrode voltage-clamp electrophysiology [AID570118, Type: Literature] | P2X purinoceptor 4 [gi:1709521] |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103634685 | | CID | 24868313 | | Outcome | Unspecified | | IC50 | 10 [uM] | | BioAssay | Antagonist activity against rat P2X4 receptor expressed in Xenopus laevis oocyte assessed as inhibition of alpha, beta-meATP-induced inward current by two-electrode voltage-clamp electrophysiology | | AID | 570118 | | BioAssay type | Literature | | Target | P2X purinoceptor 4 [gi:1709521] | | PubMed | 21207957 | | Data Table |  |
|
| 16 | [SID103634685] | Unspecified | IC50 | 10 | Antagonist activity against rat P2X2 receptor expressed in Xenopus laevis oocyte assessed as inhibition of alpha, beta-meATP-induced inward current by two-electrode voltage-clamp electrophysiology [AID570116, Type: Literature] | P2X purinoceptor 2 [gi:1352688] |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103634685 | | CID | 24868313 | | Outcome | Unspecified | | IC50 | 10 [uM] | | BioAssay | Antagonist activity against rat P2X2 receptor expressed in Xenopus laevis oocyte assessed as inhibition of alpha, beta-meATP-induced inward current by two-electrode voltage-clamp electrophysiology | | AID | 570116 | | BioAssay type | Literature | | Target | P2X purinoceptor 2 [gi:1352688] | | PubMed | 21207957 | | Data Table |  |
|
| 17 | [SID103634685] | Unspecified | Ki | 10 | Displacement of [3H]PSB0413 from human platelet P2Y12 receptor [AID375433, Type: Literature] | P2Y purinoceptor 12 [gi:21263835] |   View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103634685 | | CID | 24868313 | | Outcome | Unspecified | | Ki | 10 [uM] | | BioAssay | Displacement of [3H]PSB0413 from human platelet P2Y12 receptor | | AID | 375433 | | BioAssay type | Literature | | Target | P2Y purinoceptor 12 [gi:21263835] | | PubMed | 19463000 | | Data Table |  |
|
| 18 | [SID103634685] | Unspecified | Ki | 150 | Inhibition of rat NTPdase1 by capillary electrophoresis method [AID461579, Type: Literature] | Ectonucleoside triphosphate diphosphohydrolase 1 [gi:14547936] |   View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103634685 | | CID | 24868313 | | Outcome | Unspecified | | Ki | 150 [uM] | | BioAssay | Inhibition of rat NTPdase1 by capillary electrophoresis method | | AID | 461579 | | BioAssay type | Literature | | Target | Ectonucleoside triphosphate diphosphohydrolase 1 [gi:14547936] | | PubMed | 20146483 | | Data Table |  |
|
| 19 | [SID103634685] | Unspecified | Ki | 400 | Inhibition of rat NTPdase2 by capillary electrophoresis method [AID461581, Type: Literature] | Ectonucleoside triphosphate diphosphohydrolase 2 [gi:18202031] |   View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103634685 | | CID | 24868313 | | Outcome | Unspecified | | Ki | 400 [uM] | | BioAssay | Inhibition of rat NTPdase2 by capillary electrophoresis method | | AID | 461581 | | BioAssay type | Literature | | Target | Ectonucleoside triphosphate diphosphohydrolase 2 [gi:18202031] | | PubMed | 20146483 | | Data Table |  |
|
| 20 | [SID103634685] | Unspecified | | | Displacement of [3H]PSB0413 from human platelet P2Y12 receptor at 10 uM [AID375434, Type: Literature] | P2Y purinoceptor 12 [gi:21263835] |   View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103634685 | | CID | 24868313 | | Outcome | Unspecified | | BioAssay | Displacement of [3H]PSB0413 from human platelet P2Y12 receptor at 10 uM | | AID | 375434 | | BioAssay type | Literature | | Target | P2Y purinoceptor 12 [gi:21263835] | | PubMed | 19463000 | | Data Table |  |
|
| 21 | [SID103634685] | Unspecified | | | Cytotoxicity against human 1321N1 cells at 1 uM after 72 hrs to 144 hrs by MTT assay [AID375445, Type: Literature] | |   View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103634685 | | CID | 24868313 | | Outcome | Unspecified | | BioAssay | Cytotoxicity against human 1321N1 cells at 1 uM after 72 hrs to 144 hrs by MTT assay | | AID | 375445 | | BioAssay type | Literature | | Target | | | PubMed | 19463000 | | Data Table |  |
|
| 22 | [SID103634685] | Unspecified | | | Cytotoxicity against human 1321N1 cells at 100 uM after 72 hrs to 144 hrs by MTT assay [AID375446, Type: Literature] | |   View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103634685 | | CID | 24868313 | | Outcome | Unspecified | | BioAssay | Cytotoxicity against human 1321N1 cells at 100 uM after 72 hrs to 144 hrs by MTT assay | | AID | 375446 | | BioAssay type | Literature | | Target | | | PubMed | 19463000 | | Data Table |  |
|
| 23 | [SID103634685] | Unspecified | | | Cytotoxicity against human 1539 cells at 0.1 uM after 72 hrs to 144 hrs by MTT assay [AID375447, Type: Literature] | |   View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103634685 | | CID | 24868313 | | Outcome | Unspecified | | BioAssay | Cytotoxicity against human 1539 cells at 0.1 uM after 72 hrs to 144 hrs by MTT assay | | AID | 375447 | | BioAssay type | Literature | | Target | | | PubMed | 19463000 | | Data Table |  |
|
| 24 | [SID103634685] | Unspecified | | | Cytotoxicity against human 1539 cells at 1 uM after 72 hrs to 144 hrs by MTT assay [AID375448, Type: Literature] | |   View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103634685 | | CID | 24868313 | | Outcome | Unspecified | | BioAssay | Cytotoxicity against human 1539 cells at 1 uM after 72 hrs to 144 hrs by MTT assay | | AID | 375448 | | BioAssay type | Literature | | Target | | | PubMed | 19463000 | | Data Table |  |
|
| 25 | [SID103634685] | Unspecified | | | Cytotoxicity against human 1539 cells at 100 uM after 72 hrs to 144 hrs by MTT assay [AID375449, Type: Literature] | |   View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103634685 | | CID | 24868313 | | Outcome | Unspecified | | BioAssay | Cytotoxicity against human 1539 cells at 100 uM after 72 hrs to 144 hrs by MTT assay | | AID | 375449 | | BioAssay type | Literature | | Target | | | PubMed | 19463000 | | Data Table |  |
|
| 26 | [SID103634685] | Unspecified | | | Cytotoxicity against human 1321N1 cells at 0.1 uM after 72 hrs to 144 hrs by MTT assay [AID375432, Type: Literature] | |   View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103634685 | | CID | 24868313 | | Outcome | Unspecified | | BioAssay | Cytotoxicity against human 1321N1 cells at 0.1 uM after 72 hrs to 144 hrs by MTT assay | | AID | 375432 | | BioAssay type | Literature | | Target | | | PubMed | 19463000 | | Data Table |  |
|
| 27 | [SID50112917] | Inactive | Potency | 3.9811 | qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1) [AID485290, Type: confirmatory] | Chain A, Crystal Structure Of Human Tyrosyl-Dna Phosphodiesterase (Tdp1) [gi:20150581] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Inactive | | Potency | 3.9811 [uM] | | BioAssay | qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1) | | AID | 485290 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Human Tyrosyl-Dna Phosphodiesterase (Tdp1) [gi:20150581] | | PubMed | | | Data Table |  |
|
| 28 | [SID50112917] | Inactive | | | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin [AID2314, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Inactive | | BioAssay | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin | | AID | 2314 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 29 | [SID50112917] | Inactive | | | A qHTS for Small Molecule Inhibitors of Shiga Toxin [AID2315, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Inactive | | BioAssay | A qHTS for Small Molecule Inhibitors of Shiga Toxin | | AID | 2315 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 30 | [SID50112917] | Inactive | Potency | | qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS [AID602332, Type: confirmatory] | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS | | AID | 602332 | | BioAssay type | confirmatory | | Target | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549] | | PubMed | | | Data Table |  |
|
| 31 | [SID50112917] | Inactive | Potency | | qHTS Assay for Identification of Novel General Anesthetics [AID485281, Type: confirmatory] | Chain A, Horse Spleen Apoferritin [gi:254220970] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Identification of Novel General Anesthetics | | AID | 485281 | | BioAssay type | confirmatory | | Target | Chain A, Horse Spleen Apoferritin [gi:254220970] | | PubMed | | | Data Table |  |
|
| 32 | [SID50112917] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate [AID2107, Type: confirmatory] | alpha-galactosidase [Homo sapiens] [gi:757912] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate | | AID | 2107 | | BioAssay type | confirmatory | | Target | alpha-galactosidase [Homo sapiens] [gi:757912] | | PubMed | | | Data Table |  |
|
| 33 | [SID50112917] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate [AID2107, Type: confirmatory] | alpha-galactosidase [Homo sapiens] [gi:757912] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate | | AID | 2107 | | BioAssay type | confirmatory | | Target | alpha-galactosidase [Homo sapiens] [gi:757912] | | PubMed | | | Data Table |  |
|
| 34 | [SID50112917] | Inactive | Potency | | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide [AID1766, Type: confirmatory] | MEN1 gene product [Homo sapiens] [gi:18860839] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide | | AID | 1766 | | BioAssay type | confirmatory | | Target | MEN1 gene product [Homo sapiens] [gi:18860839] | | PubMed | | | Data Table |  |
|
| 35 | [SID50112917] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate [AID2112, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate | | AID | 2112 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 36 | [SID50112917] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate [AID2112, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate | | AID | 2112 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 37 | [SID50112917] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate [AID2112, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate | | AID | 2112 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 38 | [SID50112917] | Inactive | | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen [AID2472, Type: screening] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Inactive | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen | | AID | 2472 | | BioAssay type | screening | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 39 | [SID50112917] | Inactive | | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen [AID2472, Type: screening] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Inactive | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen | | AID | 2472 | | BioAssay type | screening | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 40 | [SID50112917] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease [AID2101, Type: confirmatory] | glucocerebrosidase [Homo sapiens] [gi:496369] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease | | AID | 2101 | | BioAssay type | confirmatory | | Target | glucocerebrosidase [Homo sapiens] [gi:496369] | | PubMed | | | Data Table |  |
|
| 41 | [SID50112917] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease [AID2101, Type: confirmatory] | glucocerebrosidase [Homo sapiens] [gi:496369] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease | | AID | 2101 | | BioAssay type | confirmatory | | Target | glucocerebrosidase [Homo sapiens] [gi:496369] | | PubMed | | | Data Table |  |
|
| 42 | [SID50112917] | Inactive | Potency | | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1469, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1469 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 43 | [SID50112917] | Inactive | Potency | | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1469, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1469 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 44 | [SID50112917] | Inactive | Potency | | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1469, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1469 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 45 | [SID50112917] | Inactive | Potency | | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1479, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1479 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 46 | [SID50112917] | Inactive | Potency | | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1479, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1479 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 47 | [SID50112917] | Inactive | Potency | | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1479, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1479 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 48 | [SID50112917] | Inactive | Potency | | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 49 | [SID50112917] | Inconclusive | Potency | 7.9433 | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide [AID1768, Type: confirmatory] | MEN1 gene product [Homo sapiens] [gi:18860839] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Inconclusive | | Potency | 7.9433 [uM] | | BioAssay | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide | | AID | 1768 | | BioAssay type | confirmatory | | Target | MEN1 gene product [Homo sapiens] [gi:18860839] | | PubMed | | | Data Table |  |
|
| 50 | [SID50112917] | Inconclusive | Potency | 11.2202 | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity [AID2546, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 50112917 | | CID | 24868313 | | Outcome | Inconclusive | | Potency | 11.2202 [uM] | | BioAssay | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2546 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|